Orion Capital Management LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1846758
CORONADO, CA
Position in HALO
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$336,561
+$94,199 QoQ
Shares Held
4,300
+14.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#440
of 664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Capital Management LLC holds $1,139,867 across 8 Biotechnology names. HALO ranks #2 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,155 | $648,719 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
4,300 | $336,561 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
953 | $90,697 | |
| 4 | CRMD |
CorMedix Inc.
|
3,000 | $23,550 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32 | $15,895 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
80 | $6,343 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
100 | $1,740 |
All Filings in HALO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,561 | 4,300 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $242,362 | 3,750 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $259,105 | 3,850 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $282,359 | 3,850 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $10,404 | 200 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $12,762 | 200 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,562 | 200 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||